The therapy, as we have developed it, is far more effective than it had once been, as we have the benefit of another 28 years of real world experimentation.
One thing that has been made evident over time, is that there is a distinct difference between the methods used in achieving results in vitro, as opposed to actual therapy where the only results possible must be achieved in vivo.
These variances are demonstrated in a large percentage of cases wherein the application of the Mortal Oscillatory Rates as called for in the original material did not produce the results expected.
At the same time, in many of these cases the ECC 1989 model seemed to be fully and clearly demonstrated.
The final assessment as to why this occurs calls on a number of different well known factors, Prediction Patterns notwithstanding, and gives rise to the following questions:
Were incorrect frequencies used? Was adequate energy applied and was it applied properly? Using the Prediction Patterns, we would eliminate data of cases that have diverged. Only a few possibilities remain.
The most likely explanation might appear to be that the structure or affected symptoms in the area of the problem have a completely different cause. In which case we must look at the case as having a cause that is not in keeping with the accepted wisdom.
It may also be that the pathogen targeted was in fact all or part of the cause, but removing it in any amount is irrelevant to the condition at the stage in which it was found. Thirdly, the structure is closed or encapsulated. Similar to an abscess, removing the pathogen is impossible until there is drainage.
Finally, the results are being gaged by an incorrect method of measurement, and do not reflect the true condition. In cases where it is suspected that the problem is caused by a virus, we would routinely refer back to the Herpes Model. The results of conventional tests will be effected seriously by the changes made in the body and in the blood stream by the therapy.
In the early stages of the therapy as applied in the Herpes application, the greatest volume of live virus is present in the system, and the immune system is being stimulated to fight it at the maximum level it is capable. Conventional testing during this phase would show an alarming amount of virus activity and very high antibodies. During the extended maintenance phase of the therapy, the user still tests positive for quite a while, even though symptoms are a thing of the past.
In cancer cases the results can be very difficult to ascertain for the reason that stimulus to the area often causes temporary added swelling. A CT scan would revel the tumor has become larger in size during this phase of the therapy.
Viral driven cancer is very rare now as opposed to the kinds of cancer that were most common during Rife’s working years. Most cancer cases today are complicated by fungus infection. Removal of the virus is not irrelevant in these cases, as it is believed that the virus contributes to the growth of the fungus. But removal of the viral component of the cancer will not normally result in a sudden reduction of tumor size, because the volume of the virus is very small as compared to the fungus and constitutes only a tiny fraction of the tumor mass.
In cases of viral tumors, viral lesions etc, symptoms are reduced rapidly and predictably, and given a reasonable follow up routine, should not return even upon re-infection. In fungal tumors, surgery is the best option.
Ordinarily surgery is dangerous in cancer cases for the reason that metastasis often follows. This is due to the disturbance and the contamination of the area by the infection as the tumor is removed. This can be lessened if the surgeon is careful in this regard. In any case, after surgery, use of the therapy is a safe and more reliable means of eliminating the remaining cancerous matter in the system.
The frequency set used in the cancer application covers the entire range, including detoxification, parasites, fungus, bacteria, virus, and immune stimulus.